Morphine Market Outlook:
Morphine Market size was over USD 20.88 billion in 2025 and is poised to exceed USD 35.67 billion by 2035, witnessing over 5.5% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of morphine is estimated at USD 21.91 billion.
The growth of the market can be attributed to the increasing prevalence of chronic diseases. Morphine has been extensively used in pain management and provides major relief to patients afflicted with pain. For instance, during the sickle cell crisis, doctors are using morphine to alleviate pain. According to the National Institutes of Health in 2024, there was a total of 8 million people suffering from sickle cells globally and 800,000 people in the U.S. These factors are augmenting the morphine market growth during the assessed time. World Health Organization released a report in June 2023, emphasizing on equal distribution of morphine as a vital medicine.
Other than this, extemporaneous opium tincture drops containing morphine are proven to be antidiarrheals and have fecal control properties. Morphine is effective in slowing down the digestion. Diarrhea is common among adults as well as children due to a shortage of adequate sanitation, hygiene, and safe water. However, doctors are finding effective ways to handle the diseases such as introducing morphine in the treatment. According to the Institute for Health Metrics and Evaluation in 2024, there is a 60% drop in global mortality from diarrheal diseases.
